Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: Consideration of fluorescent catabolite kinetics on molecular imaging

Journal of Biomedical Optics

Volumn 18, Issue 10, 2013, Pages

  Sano, Kohei ^a   Nakajima, Takahito ^a   Ali, Towhid ^a   Bartlett, Derek W ^b   Wu, Anna M ^c   Kim, Insook ^d   Paik, Chang H ^e   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ImaginAb Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAIC FREDERICK INC   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

activatable imaging; catabolism; diabody; indocyanine green; optical probe; polyethylene glycol linker

Indexed keywords

CATABOLISM; DIABODY; INDOCYANINE GREEN; NEAR-INFRARED FLUOROPHORES; OPTICAL PROBE; PROSTATE-SPECIFIC MEMBRANE ANTIGENS; REACTIVE FUNCTIONAL GROUPS; SIGNAL-TO-BACKGROUND RATIO; ANTIBODY FRAGMENT; CATABOLIC PATHWAY; POLYETHYLENE GLYCOL (PEG);

ANTIBODIES; CHEMICAL DETECTION; FUNCTIONAL GROUPS; METABOLISM; MOLECULAR IMAGING; POLYETHYLENE GLYCOLS; TUMORS;

FLUORESCENCE;

ANTIBODY; FLUORESCENT DYE; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; INDOCYANINE GREEN; MACROGOL DERIVATIVE; MEMBRANE ANTIGEN;

ANIMAL; ARTICLE; CHEMISTRY; FEMALE; FLUORESCENCE MICROSCOPY; IMMUNOLOGY; KINETICS; METABOLISM; METHODOLOGY; MOLECULAR IMAGING; MOUSE; NUDE MOUSE; TISSUE DISTRIBUTION; PROCEDURES;

ANIMALS; ANTIBODIES; ANTIGENS, SURFACE; FEMALE; FLUORESCENT DYES; GLUTAMATE CARBOXYPEPTIDASE II; INDOCYANINE GREEN; KINETICS; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MOLECULAR IMAGING; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION;

EID: 84879321124     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.18.10.101304     Document Type: Article

References (18)

1. T. A. Waldmann, "Immunotherapy: past, present and future," Nat. Med. 9(3), 269-277 (2003).
2. J.M. Reichert, et al Monoclonal antibody successes in the clinic. Nat. Biotechnol 23(9) 1073-1078 (2005).
3. A. M.Wu, "Antibodies and antimatter: the resurgence of immuno-PET," J. Nucl. Med. 50(1), 2-5 (2009).
4. C. A. Boswell and M. W. Brechbiel, "Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view," Nucl. Med. Biol. 34(7), 757-778 (2007).
5. A. M.Wu and T. Olafsen, "Antibodies for molecular imaging of cancer," Cancer J. 14(3), 191-197 (2008).
6. D. Colcher et al., "Pharmacokinetics and biodistribution of geneticallyengineered antibodies," Q. J. Nucl. Med. 42(4), 225-241 (1998).
7. A. M. Wu and P. D. Senter, "Arming antibodies: prospects and challenges for immunoconjugates," Nat. Biotechnol. 23(9), 1137-1146 (2005).
8. H. Kobayashi et al., "New strategies for fluorescent probe design in medical diagnostic imaging," Chem. Rev. 110(5), 2620-2640 (2010).
9. H. Kobayashi et al., "Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals," Chem. Soc. Rev. 40(9), 4626-4648 (2011).
10. H. Kobayashi and P. L. Choyke, "Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications," Acc. Chem. Res. 44(2), 83-90 (2011).
11. M. Ogawa et al., "In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green," Cancer Res. 69(4), 1268-1272 (2009).
12. T. Nakajima et al., "Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate," Bioconjug. Chem. 22(8), 1700-1705 (2011).
13. K. Sano et al., "In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores," Breast Cancer Res. 14(2), R61 (2012).
14. K. Sano et al., "Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes," Bioconjug. Chem. 24(5), 811-816 (2013).
15. L. Li et al., "Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody," Bioconjug. Chem. 13(5), 985-995 (2002).
16. B. E. Rogers et al., "Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo," Cancer Res. 55(23 Suppl), 5714s-5720s (1995).
17. C. Wu et al., "Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment," Bioconjug. Chem. 8(3), 365-369 (1997).
18. M. Mitsunaga et al., "Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules," Nat. Med. 17(12), 1685-1691 (2011).